Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2011-05-27
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Peripheral stem cell transplantation may be able to replace
immune cells that were destroyed by chemotherapy. Sometimes the transplanted cells are
rejected by the body's tissues. Peripheral stem cell transplantation with the person's own
stem cells followed by donor peripheral stem cell transplantation may prevent this from
happening.
PURPOSE: Phase II trial to study the effectiveness of combining chemotherapy with autologous
peripheral stem cell transplantation and donor peripheral stem cell transplantation in
treating patients who have multiple myeloma.